Related Experiment Video

Updated: Aug 12, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

[Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B]

Kyung Hwan Kim1, Il Hwan Na, Jae Moon Cha

  • 1Department of Internal Medicine, Samsun Hospital, Pusan National University College of Medicine1, Busan, Korea.

Taehan Kan Hakhoe Chi = the Korean Journal of Hepatology
|December 27, 2003
PubMed

Insights

In HBeAg-negative chronic hepatitis B (CHB), higher serum HBV DNA levels correlate with elevated ALT, aiding treatment decisions. This study confirms a significant link between HBV DNA and ALT in these patients.

Area of Science:

  • Hepatology
  • Virology
  • Biochemistry

Context:

  • HBeAg-negative chronic hepatitis B (CHB) presents a challenge due to undefined treatment thresholds.
  • Accurate assessment of viral load and liver inflammation is crucial for managing CHB.

Purpose:

  • To evaluate serum HBV DNA and transaminase levels in HBeAg-negative CHB patients.
  • To investigate the correlation between HBV DNA and ALT levels in this cohort.

Summary:

  • Serum HBV DNA levels were significantly higher in HBeAg-negative CHB patients with elevated ALT (>/= 2X UNL) compared to those with lower ALT (< 2X UNL).
  • A significant positive correlation (r=0.416, p<0.001) was observed between serum ALT and HBV DNA levels.
  • HBV DNA levels did not significantly differ between patients with and without cirrhosis.

Impact:

  • Findings suggest that serum ALT levels can serve as a surrogate marker for HBV DNA levels in HBeAg-negative CHB.
  • This correlation may assist clinicians in making more informed treatment decisions for HBeAg-negative CHB patients.
Abstract

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...